Carotid endarterectomy is associated with lower rates of reintervention compared to carotid stenting
Authors:
- Elizabeth L. GeorgeEGElizabeth L. George
- Sabina M. SorondoSSSabina M. Sorondo
- Arash FereydooniAFArash Fereydooni
- Jordan R. SternJSJordan R. Stern
Preprint
Abstract
Objectives Perioperative outcomes for carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS) have been well studied. Less is known about the durability and reintervention rates of each, particularly in the era of transcarotid artery revascularization (TCAR). We sought to compare real-world rates of ipsilateral reintervention, stroke, and death in patients undergoing CEA, TFCAS, and TCAR. Methods The Vascular Quality Initiative (VQI) was matched to Medicare claims via the Vascular Implant Surveillance and Implantation Network (VISION) database to identify patients who had primary carotid revascularization from December 2016 to December 2019 in a n observational cohort study. The primary outcome was ipsilateral reintervention; secondary outcomes included stroke and mortality. After 1:1 greedy matching using propensity scores, patients who underwent CEA and carotid artery stenting (CAS) via either transcarotid or transfemoral approach were compared using time-dependent Cox regression models. A separate propensity matched analysis was then performed to compare TFCAS and TCAR. Kaplan-Meier curves were compared using log rank tests. Results After propensity matching (N=27,944 patients), we compared 4705 patients in each group. Risk of re-intervention was increased within 6 months for CAS (HR: 1.97; 95% CI: 1.11-3.50; pConclusions CEA portends a lower risk of reintervention than CAS, particularly within the first 6 months after revascularization. On subgroup analysis of stenting modalities, TCAR had a lower hazard of longer-term reintervention compared to TFCAS.Keywords
This publication has 21 references indexed in Scilit:
- Seven years of the transcarotid artery revascularization surveillance project, comparison to transfemoral stenting and endarterectomyJournal of Vascular Surgery, 2024
- Use of Transcarotid Artery Revascularization, Transfemoral Carotid Artery Stenting, and Carotid Endarterectomy in the US From 2015 to 2019JAMA Network Open, 2022
- Transcarotid artery revascularization is safe in necks with anatomy hostile for carotid endarterectomyJournal of Vascular Surgery, 2022
- One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trialJournal of Vascular Surgery, 2022
- Carotid Wallstent Versus Roadsaver Stent and Distal Versus Proximal Protection on Cerebral Microembolization During Carotid Artery StentingJACC: Cardiovascular Interventions, 2020
- In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality InitiativeJournal of Vascular Surgery, 2020
- Comparing Long-term Mortality After Carotid Endarterectomy vs Carotid Stenting Using a Novel Instrumental Variable Method for Risk Adjustment in Observational Time-to-Event DataJAMA Network Open, 2018
- Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014JAMA, 2017
- Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversalJournal of Vascular Surgery, 2015
- Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States, 2005Journal of Vascular Surgery, 2008